MSIplus for Integrated Colorectal Cancer Molecular Testing by Next-Generation Sequencing

Journal of Molecular Diagnostics

Volumn 17, Issue 6, 2015, Pages 705-714

  Hempelmann, Jennifer A ^a   Scroggins, Sheena M ^a   Pritchard, Colin C ^a   Salipante, Stephen J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; DNA FRAGMENT; K RAS PROTEIN;

ALLELE; AMPLICON; ARTICLE; AUTOMATION; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COLORECTAL CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; GENE MUTATION; GENE TARGETING; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; MICROSATELLITE MARKER; MOLECULAR DIAGNOSIS; MULTIPLEX POLYMERASE CHAIN REACTION; NEXT GENERATION SEQUENCING; NUCLEOTIDE SEQUENCE; ONCOGENE N RAS; PHENOTYPIC VARIATION; PRACTICE GUIDELINE; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS; COLORECTAL TUMOR; GENETICS; HIGH THROUGHPUT SEQUENCING; MUTATION; PHENOTYPE; PROCEDURES;

COLORECTAL NEOPLASMS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MICROSATELLITE INSTABILITY; MUTATION; PHENOTYPE; SENSITIVITY AND SPECIFICITY;

EID: 84943630815     PISSN: 15251578     EISSN: 19437811     Source Type: Journal    
DOI: 10.1016/j.jmoldx.2015.05.008     Document Type: Article

References (52)

1. M.A. Jenkins, S. Hayashi, A.M. O'Shea, L.J. Burgart, T.C. Smyrk, D. Shimizu, P.M. Waring, A.R. Ruszkiewicz, A.F. Pollett, M. Redston, M.A. Barker, J.A. Baron, G.R. Casey, J.G. Dowty, G.G. Giles, P. Limburg, P. Newcomb, J.P. Young, M.D. Walsh, S.N. Thibodeau, N.M. Lindor, L. Lemarchand, S. Gallinger, R.W. Haile, J.D. Potter, J.L. Hopper, J.R. Jass Colon Cancer Family Registry Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study Gastroenterology 133 2007 48 56
2. L.C. Beamer, M.L. Grant, C.R. Espenschied, K.R. Blazer, H.L. Hampel, J.N. Weitzel, and D.J. MacDonald Reflex immunohistochemistry and microsatellite instability testing of colorectal tumors for Lynch syndrome among US cancer programs and follow-up of abnormal results J Clin Oncol 30 2012 1058 1063
3. E. Vilar, and S.B. Gruber Microsatellite instability in colorectal cancer: the stable evidence Nat Rev Clin Oncol 7 2010 153 162
4. C.M. Ribic, D.J. Sargent, M.J. Moore, S.N. Thibodeau, A.J. French, R.M. Goldberg, S.R. Hamilton, P. Laurent-Puig, R. Gryfe, L.E. Shepherd, D. Tu, M. Redston, and S. Gallinger Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer N Engl J Med 349 2003 247 257
5. A. Goel, T. Nagasaka, R. Hamelin, and C.R. Boland An optimized pentaplex PCR for detecting DNA mismatch repair-deficient colorectal cancers PLoS One 5 2010 e9393
6. A. de la Chapelle, and H. Hampel Clinical relevance of microsatellite instability in colorectal cancer J Clin Oncol 28 2010 3380 3387
7. NCCN Guidelines(R) Updates J Natl Compr Canc Netw 11 2013 xxxii xxxvi
8. T.P. Plesec, and J.L. Hunt KRAS mutation testing in colorectal cancer Adv Anat Pathol 16 2009 196 203
9. W. De Roock, B. Claes, D. Bernasconi, J. De Schutter, B. Biesmans, G. Fountzilas, and et al. Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis Lancet Oncol 11 2010 753 762
10. J.Y. Douillard, K.S. Oliner, S. Siena, J. Tabernero, R. Burkes, M. Barugel, Y. Humblet, G. Bodoky, D. Cunningham, J. Jassem, F. Rivera, I. Kocakova, P. Ruff, M. Blasinska-Morawiec, M. Smakal, J.L. Canon, M. Rother, R. Williams, A. Rong, J. Wiezorek, R. Sidhu, and S.D. Patterson Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer N Engl J Med 369 2013 1023 1034
11. E. Van Cutsem, C.H. Kohne, I. Lang, G. Folprecht, M.P. Nowacki, S. Cascinu, I. Shchepotin, J. Maurel, D. Cunningham, S. Tejpar, M. Schlichting, A. Zubel, I. Celik, P. Rougier, and F. Ciardiello Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status J Clin Oncol 29 2011 2011 2019
12. F. Di Nicolantonio, M. Martini, F. Molinari, A. Sartore-Bianchi, S. Arena, P. Saletti, S. De Dosso, L. Mazzucchelli, M. Frattini, S. Siena, and A. Bardelli Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer J Clin Oncol 26 2008 5705 5712
13. C. Bokemeyer, E. Van Cutsem, P. Rougier, F. Ciardiello, S. Heeger, M. Schlichting, I. Celik, and C.H. Kohne Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: pooled analysis of the CRYSTAL and OPUS randomised clinical trials Eur J Cancer 48 2012 1466 1475
14. C.R. Boland, S.N. Thibodeau, S.R. Hamilton, D. Sidransky, J.R. Eshleman, R.W. Burt, S.J. Meltzer, M.A. Rodriguez-Bigas, R. Fodde, G.N. Ranzani, and S. Srivastava A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer Cancer Res 58 1998 5248 5257
15. A. Umar, C.R. Boland, J.P. Terdiman, S. Syngal, A. de la Chapelle, J. Ruschoff, R. Fishel, N.M. Lindor, L.J. Burgart, R. Hamelin, S.R. Hamilton, R.A. Hiatt, J. Jass, A. Lindblom, H.T. Lynch, P. Peltomaki, S.D. Ramsey, M.A. Rodriguez-Bigas, H.F. Vasen, E.T. Hawk, J.C. Barrett, A.N. Freedman, and S. Srivastava Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability J Natl Cancer Inst 96 2004 261 268
16. J.W. Bacher, L.A. Flanagan, R.L. Smalley, N.A. Nassif, L.J. Burgart, R.B. Halberg, W.M. Megid, and S.N. Thibodeau Development of a fluorescent multiplex assay for detection of MSI-High tumors Dis Markers 20 2004 237 250
17. N.M. Lindor, L.J. Burgart, O. Leontovich, R.M. Goldberg, J.M. Cunningham, D.J. Sargent, C. Walsh-Vockley, G.M. Petersen, M.D. Walsh, B.A. Leggett, J.P. Young, M.A. Barker, J.R. Jass, J. Hopper, S. Gallinger, B. Bapat, M. Redston, and S.N. Thibodeau Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors J Clin Oncol 20 2002 1043 1048
18. J. Shia Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome, part I: the utility of immunohistochemistry J Mol Diagn 10 2008 293 300
19. L. Zhang Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome, part II: the utility of microsatellite instability testing J Mol Diagn 10 2008 301 307
20. A. Müller, G. Giuffre, T.B. Edmonston, M. Mathiak, B. Roggendorf, E. Heinmöller, T. Brodegger, G. Tuccari, E. Mangold, R. Buettner, J. Rüschoff German HNPCC Consortium German Cancer Aid (Deutsche Krebshife) Challenges and pitfalls in HNPCC screening by microsatellite analysis and immunohistochemistry J Mol Diagn 6 2004 308 315
21. T. Ikenoue, Y. Hikiba, F. Kanai, H. Ijichi, G. Togo, M. Ohta, H. Watabe, Y. Yamaji, M. Okamoto, J. Aragaki, M. Matsumura, T. Kawabe, and M. Omata Rapid detection of mutations in the BRAF gene using real-time polymerase chain reaction and melting curve analysis Cancer Genet Cytogenet 149 2004 68 71
22. M.N. Nikiforova, R.A. Lynch, P.W. Biddinger, E.K. Alexander, G.W. Dorn 2nd, G. Tallini, T.G. Kroll, and Y.E. Nikiforov RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma J Clin Endocrinol Metab 88 2003 2318 2326
23. K. Sakai, A. Yoneshige, A. Ito, Y. Ueda, S. Kondo, H. Nobumasa, Y. Fujita, Y. Togashi, M. Terashima, M.A. De Velasco, S. Tomida, and K. Nishio Performance of a novel KRAS mutation assay for formalin-fixed paraffin embedded tissues of colorectal cancer Springerplus 4 2015 7
24. K. Qu, Q. Pan, X. Zhang, L. Rodriguez, K. Zhang, H. Li, A. Ho, H. Sanders, A. Sferruzza, S.M. Cheng, D. Nguyen, D. Jones, and F. Waldman Detection of BRAF V600 mutations in metastatic melanoma: comparison of the Cobas 4800 and Sanger sequencing assays J Mol Diagn 15 2013 790 795
25. J.E. Oh, H.S. Lim, C.H. An, E.G. Jeong, J.Y. Han, S.H. Lee, and N.J. Yoo Detection of low-level KRAS mutations using PNA-mediated asymmetric PCR clamping and melting curve analysis with unlabeled probes J Mol Diagn 12 2010 418 424
26. C.C. Pritchard, L. Akagi, P.L. Reddy, L. Joseph, and J.F. Tait COLD-PCR enhanced melting curve analysis improves diagnostic accuracy for KRAS mutations in colorectal carcinoma BMC Clin Pathol 10 2010 6
27. J. Li, L. Wang, H. Mamon, M.H. Kulke, R. Berbeco, and G.M. Makrigiorgos Replacing PCR with COLD-PCR enriches variant DNA sequences and redefines the sensitivity of genetic testing Nat Med 14 2008 579 584
28. M. Westwood, T. van Asselt, B. Ramaekers, P. Whiting, M. Joore, N. Armstrong, C. Noake, J. Ross, J. Severens, and J. Kleijnen KRAS mutation testing of tumours in adults with metastatic colorectal cancer: a systematic review and cost-effectiveness analysis Health Technol Assess 18 2014 1 132
29. C.C. Pritchard, C. Smith, S.J. Salipante, M.K. Lee, A.M. Thornton, A.S. Nord, C. Gulden, S.S. Kupfer, E.M. Swisher, R.L. Bennett, A.P. Novetsky, G.P. Jarvik, O.I. Olopade, P.J. Goodfellow, M.C. King, J.F. Tait, and T. Walsh ColoSeq provides comprehensive lynch and polyposis syndrome mutational analysis using massively parallel sequencing J Mol Diagn 14 2012 357 366
30. G.M. Frampton, A. Fichtenholtz, G.A. Otto, K. Wang, S.R. Downing, J. He, and et al. Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing Nat Biotechnol 31 2013 1023 1031
31. C.C. Pritchard, S.J. Salipante, K. Koehler, C. Smith, S. Scroggins, B. Wood, D. Wu, M.K. Lee, S. Dintzis, A. Adey, Y. Liu, K.D. Eaton, R. Martins, K. Stricker, K.A. Margolin, N. Hoffman, J.E. Churpek, J.F. Tait, M.C. King, and T. Walsh Validation and implementation of targeted capture and sequencing for the detection of actionable mutation, copy number variation, and gene rearrangement in clinical cancer specimens J Mol Diagn 16 2014 56 67
32. C.E. Cottrell, H. Al-Kateb, A.J. Bredemeyer, E.J. Duncavage, D.H. Spencer, H.J. Abel, C.M. Lockwood, I.S. Hagemann, S.M. O'Guin, L.C. Burcea, C.S. Sawyer, D.M. Oschwald, J.L. Stratman, D.A. Sher, M.R. Johnson, J.T. Brown, P.F. Cliften, B. George, L.D. McIntosh, S. Shrivastava, T.T. Nguyen, J.E. Payton, M.A. Watson, S.D. Crosby, R.D. Head, R.D. Mitra, R. Nagarajan, S. Kulkarni, K. Seibert, H.W. Virgin 4th, J. Milbrandt, and J.D. Pfeifer Validation of a next-generation sequencing assay for clinical molecular oncology J Mol Diagn 16 2014 89 105
33. O. Harismendy, R.B. Schwab, L. Bao, J. Olson, S. Rozenzhak, S.K. Kotsopoulos, S. Pond, B. Crain, M.S. Chee, K. Messer, D.R. Link, and K.A. Frazer Detection of low prevalence somatic mutations in solid tumors with ultra-deep targeted sequencing Genome Biol 12 2011 R124
34. J.B. Hiatt, C.C. Pritchard, S.J. Salipante, B.J. O'Roak, and J. Shendure Single molecule molecular inversion probes for targeted, high-accuracy detection of low-frequency variation Genome Res 23 2013 843 854
35. S.J. Salipante, S.M. Scroggins, H.L. Hampel, E.H. Turner, and C.C. Pritchard Microsatellite instability detection by next generation sequencing Clin Chem 60 2014 1192 1199
36. Y. Lu, T.D. Soong, and O. Elemento A novel approach for characterizing microsatellite instability in cancer cells PLoS One 8 2013 e63056
37. B. Niu, K. Ye, Q. Zhang, C. Lu, M. Xie, M.D. McLellan, M.C. Wendl, and L. Ding MSIsensor: microsatellite instability detection using paired tumor-normal sequence data Bioinformatics 30 2014 1015 1016
38. T.M. Kim, P.W. Laird, and P.J. Park The landscape of microsatellite instability in colorectal and endometrial cancer genomes Cell 155 2013 858 868
39. A. McKenna, M. Hanna, E. Banks, A. Sivachenko, K. Cibulskis, A. Kernytsky, K. Garimella, D. Altshuler, S. Gabriel, M. Daly, and M.A. DePristo The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data Genome Res 20 2010 1297 1303
40. C. Dorard, A. de Thonel, A. Collura, L. Marisa, M. Svrcek, A. Lagrange, G. Jego, K. Wanherdrick, A.L. Joly, O. Buhard, J. Gobbo, V. Penard-Lacronique, H. Zouali, E. Tubacher, S. Kirzin, J. Selves, G. Milano, M.C. Etienne-Grimaldi, L. Bengrine-Lefevre, C. Louvet, C. Tournigand, J.H. Lefevre, Y. Parc, E. Tiret, J.F. Flejou, M.P. Gaub, C. Garrido, and A. Duval Expression of a mutant HSP110 sensitizes colorectal cancer cells to chemotherapy and improves disease prognosis Nat Med 17 2011 1283 1289
41. Z. Shen, W. Qu, W. Wang, Y. Lu, Y. Wu, Z. Li, X. Hang, X. Wang, D. Zhao, and C. Zhang MPprimer: a program for reliable multiplex PCR primer design BMC Bioinformatics 11 2010 143
42. L.A. Clarke, C.S. Rebelo, J. Goncalves, M.G. Boavida, and P. Jordan PCR amplification introduces errors into mononucleotide and dinucleotide repeat sequences Mol Pathol 54 2001 351 353
43. S.J. Salipante, and M.S. Horwitz Phylogenetic fate mapping Proc Natl Acad Sci U S A 103 2006 5448 5453
44. H. Li, and R. Durbin Fast and accurate short read alignment with Burrows-Wheeler transform Bioinformatics 25 2009 1754 1760
45. H. Li, B. Handsaker, A. Wysoker, T. Fennell, J. Ruan, N. Homer, G. Marth, G. Abecasis, R. Durbin 1000 Genomes Project Data Processing Subgroup The Sequence Alignment/Map format and SAMtools Bioinformatics 25 2009 2078 2079
46. M.A. DePristo, E. Banks, R. Poplin, K.V. Garimella, J.R. Maguire, C. Hartl, A.A. Philippakis, G. del Angel, M.A. Rivas, M. Hanna, A. McKenna, T.J. Fennell, A.M. Kernytsky, A.Y. Sivachenko, K. Cibulskis, S.B. Gabriel, D. Altshuler, and M.J. Daly A framework for variation discovery and genotyping using next-generation DNA sequencing data Nat Genet 43 2011 491 498
47. D.C. Koboldt, Q. Zhang, D.E. Larson, D. Shen, M.D. McLellan, L. Lin, C.A. Miller, E.R. Mardis, L. Ding, and R.K. Wilson VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing Genome Res 22 2012 568 576
48. I. Kinde, J. Wu, N. Papadopoulos, K.W. Kinzler, and B. Vogelstein Detection and quantification of rare mutations with massively parallel sequencing Proc Natl Acad Sci U S A 108 2011 9530 9535
49. M.W. Schmitt, S.R. Kennedy, J.J. Salk, E.J. Fox, J.B. Hiatt, and L.A. Loeb Detection of ultra-rare mutations by next-generation sequencing Proc Natl Acad Sci U S A 109 2012 14508 14513
50. T.M. Pawlik, C.P. Raut, and M.A. Rodriguez-Bigas Colorectal carcinogenesis: MSI-H versus MSI-L Dis Markers 20 2004 199 206
51. I. Tomlinson, S. Halford, L. Aaltonen, N. Hawkins, and R. Ward Does MSI-low exist? J Pathol 197 2002 6 13
52. H. Hampel, W. Frankel, J. Panescu, J. Lockman, K. Sotamaa, D. Fix, I. Comeras, J. La Jeunesse, H. Nakagawa, J.A. Westman, T.W. Prior, M. Clendenning, P. Penzone, J. Lombardi, P. Dunn, D.E. Cohn, L. Copeland, L. Eaton, J. Fowler, G. Lewandowski, L. Vaccarello, J. Bell, G. Reid, and A. de la Chapelle Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients Cancer Res 66 2006 7810 7817